- Home
- ORGO vs QSI Comparison
ORGO vs QSI Comparison
Compare ORGO & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | QSI |
|---|---|---|
| Founded | 1985 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.0M | 165.6M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ORGO | QSI |
|---|---|---|
| Price | $0.99 | $1.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $2.00 | ★ $2.30 |
| AVG Volume (30 Days) | 601.6K | ★ 8.4M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.55 | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $1.10 | $0.69 |
| 52 Week High | $7.08 | $2.73 |
Technical Indicators
Market Signals| Indicator | ORGO | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 18.64 | 50.63 |
| Support Level | N/A | $0.81 |
| Resistance Level | $2.69 | $1.32 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.00 | 36.42 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.